Oriens Travel & Hotel Management Corp. announced that the company has appointed Mr. Melvin Pereira as its new Chief Executive Officer, President & Director.
Regenerative Medical Technology Group Inc.
Equities
MSSV
US59071L1035
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0429 USD | +7.25% |
|
-2.94% | +487.67% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+487.67% | 536K | |
+16.71% | 44.48B | |
+43.23% | 40.57B | |
-7.92% | 38.82B | |
+33.09% | 32.22B | |
-7.10% | 27.84B | |
+14.46% | 26.79B | |
+46.73% | 14.31B | |
+34.07% | 12.7B | |
-7.61% | 11.23B |
- Stock Market
- Equities
- MSSV Stock
- News Regenerative Medical Technology Group Inc.
- Oriens Travel and Hotel Management Corp. Appoints Melvin Pereira as New Chief Executive Officer, President & Director